Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

MiRNA Sequencing and Assays Market Report: New Changes and Technology, Drivers, and Growth by 2024

MiRNA Sequencing and Assays Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region – Global Forecast To 2024″The miRNA sequencing and assay market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=109895336

Browse in-depth TOC on “MiRNA Sequencing and Assays Market”

61 – Tables

24– Figures

98 – Pages

Key Market Players

Major vendors in the Microscope software market include Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), and NEB (UK), among others.

Sequencing consumables are projected to hold the largest share of the miRNA sequencing and assay market during the forecast period.

Based on product, the miRNA sequencing & assays market is segmented into library preparation kits and sequencing consumables. Sequencing consumables dominated the market with a larger share in 2018. The large share of this segment can primarily be attributed to the growing demand for consumables and increasing adoption of small RNA sequencing.

The research and academic institutes end-user segment held the largest share of the market in 2018

Based on end users, the miRNA sequencing & assays market is segmented into academic and research institutes and contract research organizations. In 2018, academic and research institutes accounted for the largest share of the miRNA sequencing & assays market. The large share of this segment can be attributed to the availability of research grants and the increasing focus of market players on providing efficient miRNA sequencing products and services for research applications.

Request 10% Customization:https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=109895336

This research report categorizes the miRNA sequencing and assays market based on products, technology, and end user.

By product, the miRNA sequencing and assays market is segmented as follows:

  • Sequencing Consumables
  • Library Preparation Kits

By technology, the miRNA sequencing and assays market is segmented as follows:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • SOLiD
  • Nanopore Sequencing

By end user, the miRNA sequencing and assays market for Life Sciences is segmented as follows:

  • Academic & Research Institutes
  • CROs

North America dominated the miRNA sequencing and assay market in 2018

North America is estimated to account for the largest share of the market in 2018. Factors such as increasing investments in the development of sequencing, growing research in the fields of genomics and RNA biology, and the rising demand for economical, high-throughput techniques for miRNA analysis are driving the growth of the miRNA sequencing & assays market in this region.

Report Link- ( MiRNA Sequencing and Assays Market )

Recent Developments:

  • In 2018, Illumina partnered with Thermo Fisher to provide Ampliseq technology solutions to its customers.
  • In 2017, Takara Bio acquired WaferGen to augment and expand Takara Bio’s worldwide commercial offerings in transcriptomics and create new market opportunities in other areas of genomics.
  • In 2016, PerkinElmer acquired Bioo Scientific, which provides consumables solutions for life science research, and food and animal-feed safety testing.

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their pain points around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: [email protected]

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/flow-imaging-microscopy-analysis.asp

The post MiRNA Sequencing and Assays Market Report: New Changes and Technology, Drivers, and Growth by 2024 appeared first on MarketsandMarkets Blog.



This post first appeared on Markets Research Report, Business Research, Market, please read the originial post: here

Share the post

MiRNA Sequencing and Assays Market Report: New Changes and Technology, Drivers, and Growth by 2024

×

Subscribe to Markets Research Report, Business Research, Market

Get updates delivered right to your inbox!

Thank you for your subscription

×